Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI-Powered moroccan diet could help tame diabetes

NCT ID NCT07404280

Disease control Sponsor: Avicenna Military Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a diet plan based on traditional Moroccan foods, guided by artificial intelligence and continuous glucose monitors, can help adults with type 2 diabetes control their blood sugar. Fifty participants will wear a glucose monitor, keep food diaries, and receive personalized meal advice. Researchers will track changes in blood sugar levels, weight, and waist size over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Moroccan-adapted nutritional plan with continuous glucose monitoring feedback
What this could lead to
If successful, this could show that a culturally tailored diet plan helps people with type 2 diabetes better manage their blood sugar levels.
What could go wrong
This is a small, early-stage study with only 50 participants and no control group, so results may not apply broadly. Diet adherence can vary, and the intervention may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed diagnosis of T2D by a healthcare professional. * Age 18 years or older. * A glycated hemoglobin (HbA1c) level less than 10%. * Capacity to provide informed written consent and follow the study procedures. Exclusion Criteria: * Non-diabetic subjects. * Type 1 diabetes or secondary diabetes. * Age younger than 18 years. * Pregnancy or planned pregnancy during the study period. * HbA1c level greater than 10%. * Chronic renal insufficiency or hepatic disease. * Pathologies of the digestive tract that affect nutrient absorption. * Known food allergies requiring highly specific restricted diets.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes (T2DM)

Contacts and locations

Locations

  • Avicenna Military Hospital of Marrakech

    Marrakesh, Marrakesh-Safi, 40160, Morocco

More trials for these conditions

Other studies related to the condition(s) this trial covers.